Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Astragaloside II (Astrasieversianin VIII) is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 215.00 | |
50 mg | In stock | $ 318.00 | |
100 mg | In stock | $ 469.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 133.00 |
Description | Astragaloside II (Astrasieversianin VIII) is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways. |
Source |
Synonyms | Astrasieversianin VIII |
Molecular Weight | 827.01 |
Formula | C43H70O15 |
CAS No. | 84676-89-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMSO: 100 mg/mL (120.92 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Astragaloside II 84676-89-1 Stem Cells TGF-beta/Smad Inhibitor inhibit Astrasieversianin VIII inhibitor